BEPERIDIUM

Details

Stereochemistry	RACEMIC
Molecular Formula	C23H34N3O3
Molecular Weight	400.5344
Optical Activity	( + / - )
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	1

SHOW SMILES / InChI

Structure Search

SMILES

CC[N@+]1(C)CC[C@@H](CC1)OC(=O)[C@H](N2CCCCCC2)C3=NOC4=C3C=CC=C4

InChI

InChIKey=CNTJFDRCJSXDAU-WTSFKKHRSA-N

InChI=1S/C23H34N3O3/c1-3-26(2)16-12-18(13-17-26)28-23(27)22(25-14-8-4-5-9-15-25)21-19-10-6-7-11-20(19)29-24-21/h6-7,10-11,18,22H,3-5,8-9,12-17H2,1-2H3/q+1/t18-,22-,26+/m1/s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3741526

Beperidium (also known as SX-810 ) is a competitive antagonist against acetylcholine. Experiments on animal have shown that this compound exhibited spasmolytic and antiulcerative activities without exerting systemic antimuscarinic side effects.

Approval Year

PubMed

Title	Date	PubMed
Pharmacological properties of the novel antimuscarinic agent 4-[2-(1,2-benzisoxazol-3-yl)-2-(hexahydro-1H-azepin-1-yl)a cetoxy]-1-et hyl-1- methylpiperidinium iodide.	1986-06	3741526

Patents

Name

Type

Language

BEPERIDIUM

Common Name

English

BEPERIDIUM CATION

Preferred Name

English

BEPERIDIUM ION

Common Name

English

PIPERIDINIUM, 4-((2-(1,2-BENZISOXAZOL-3-YL)-2-(HEXAHYDRO-1H-AZEPIN-1-YL)ACETYL)OXY)-1-ETHYL-1-METHYL-

Systematic Name

English

Code System Code Type Description

CAS

86434-70-0

Created by admin on Mon Mar 31 18:00:49 GMT 2025 , Edited by admin on Mon Mar 31 18:00:49 GMT 2025

PRIMARY

PUBCHEM

91617581

Created by admin on Mon Mar 31 18:00:49 GMT 2025 , Edited by admin on Mon Mar 31 18:00:49 GMT 2025

PRIMARY

FDA UNII

OT9SNF3EEF

Created by admin on Mon Mar 31 18:00:49 GMT 2025 , Edited by admin on Mon Mar 31 18:00:49 GMT 2025

PRIMARY

ACTIVE MOIETY


					OT9SNF3EEF

BEPERIDIUM

Details

SMILES

InChI

DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3741526

Approval Year

PubMed

Patents

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3741526